Consistent with our mouse experiments described above (Figure 1), all three cell lines showed a significant increase in DNA methylation at the CpG shore of the SHH promoter region (Figure 6A,B and Figure 6—figure supplement 1A) and demonstrated basal characteristics of urothelial carcinoma with low levels of SHH expression. Here, SHH is linked to urothelial carcinoma.